8-(BENZYLOXY)-5-(2-CHLOROACETYL)QUINOLIN-2(1H)-ONE, 95%, 100mg

tert-Butyl N-[(1R,3R)-3-hydroxycyclohexyl]carbamate, 98%, 5g

Sodium methanesulfonate, 97%, 500g

1,3-Diphenylbutane, 97.0%, 100mg

Ethyl morpholine-2-carboxylate, 98%, 1g

2,4-Dibromo-1,5-difluoro-3-nitrobenzene, 95.0%, 5g

2'-Deoxyuridine>99.0%(HPLC)5g

6-(Tritylthio)hexanoic acid, 99.0%, 100mg

GLYCEROL PHENYLBUTYRATE, 95%, 100mg

(S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one, 98%, 10g

(3-Carbamoyl-5-fluorophenyl)boronic acid, 98.0%, 250mg

5-(azetidin-3-yl)-1H-1,2,3,4-tetrazole hydrochloride, 95%, 250mg

E-Plan phase EPLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm